Esurgi develops hardware and software solutions for medical devices and injury prevention. Their focus areas include ACL injuries, low back pain, physical therapy, and Alzheimer's disease.
Funding
Funding not disclosed
Founders
Product
Problem
Patients recovering from musculoskeletal injuries, such as ACL tears or lower back pain, often require extensive physical therapy to regain strength and mobility. Traditional physical therapy methods may lack the real-time feedback necessary to optimize muscle engagement and movement patterns, potentially hindering recovery and increasing the risk of re-injury.
Solution
Esurgi is a biotech company that provides interactive, automated, and informative products designed to improve the relationship between healthcare providers and their patients. Their flagship product, the Biostabilizer, is a biofeedback unit that aims to revolutionize physical therapy by providing real-time feedback on muscle activity. By detecting individual biomechanical concerns earlier and automating repeatable tasks, Esurgi's products help patients understand how their behavior can be a cause of current and potentially future injuries. The Biostabilizer and other potential products like Joint Spy and LeMo, aim to enhance the preservation of health and improve the quality of life.
Target Audience
Esurgi's primary customers are healthcare providers, including physical therapists, medical officers, and prescribers, seeking to improve patient outcomes in musculoskeletal rehabilitation, as well as patients recovering from injuries like ACL tears and lower back pain.
Features
- Biofeedback unit providing real-time feedback on muscle activity
- Simple to administer and efficiently improves quality of life
- Detects individual biomechanical concerns earlier
- Automates repeatable tasks in physical therapy
- Interactive tools to educate patients on the relationship between behavior and injury